Century Therapeutics, Inc. (IPSC)
IPSC has a market cap or net worth of $567.91 million. The enterprise value is $229.62 million.
The next earnings date is Thursday, August 11, 2022, before market open.
|Estimated Earnings Date||Aug 11, 2022|
IPSC has 58.85 million shares outstanding. The number of shares has increased by 643.13% in one year.
|Shares Change (YoY)||+643.13%|
|Shares Change (QoQ)||+76.13%|
|Owned by Insiders (%)||36.59%|
|Owned by Institutions (%)||60.16%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 16.62, with a Debt / Equity ratio of 0.06.
|Debt / Equity||0.06|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -27.80%, which is considered low. The company has a ROIC of -32.30%.
|Return on Equity (ROE)||-27.80%|
|Return on Assets (ROA)||-23.60%|
|Return on Capital (ROIC)||-32.30%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$676,406|
In the past 12 months, IPSC has paid $59,000 in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-64.76%|
|50-Day Moving Average||8.60|
|200-Day Moving Average||11.79|
|Average Volume (30 Days)||100,231|
Short Selling Information
The latest short interest is 3.27 million, so 5.55% of the outstanding shares have been sold short.
|Short % of Shares Out||5.55%|
|Short % of Float||16.08%|
|Short Ratio (days to cover)||44.76|
|Earnings Per Share (EPS)||-$2.57|
The company has $362.74 million in cash and $24.45 million in debt, giving a net cash position of $338.29 million or $5.75 per share.
|Cash & Cash Equivalents||362.74M|
|Net Cash Per Share||$5.75|
|Book Value Per Share||6.57|
In the last 12 months, operating cash flow was $19.93 million and capital expenditures -$47.15 million, giving a free cash flow of -$27.22 million.
|Operating Cash Flow||19.93M|
|Free Cash Flow||-27.22M|
|FCF Per Share||n/a|
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for IPSC is $25.70, which is 166.32% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||166.32%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|